The Time for a Confirmative Necrotizing Enterocolitis Probiotics Prevention Trial in the Extremely Low Birth Weight Infant in North America Is Now! - 22/07/14

, Samuli Rautava, MD, PhD 3, Aideen M. Moore, MD, FRCPC 1, Josef Neu, MD 4, Philip M. Sherman, MD, FRCPC 1Keyword : ELBW, NEC, NICU, RCT, VLBW
Le texte complet de cet article est disponible en PDF.
Plan
| T.A. has received honoraria for lectures and funding for a clinical trial (ClinicalTrials.gov ID: NCT01285830) from Biogaia AB, Sweden. P.S. has received research support from Lallemand Human Nutrition (Quebec, Canada), honoraria related to probiotic continuing medical education presentations from Abbot Nutrition, Mead Johnson Nutrition, Nestlé Nutrition, and Procter & Gamble, and is the recipient of a Canada Research Chair in Gastrointestinal Disease (MOP-89894 and IOP-92890). J.N. is on the scientific advisory panel of Medela and Mead Johnson Nutrition, consultant for Infants Bacterial Therapeutics, and has received honoraria for lectures from Abbot Nutrition, Danone, Mead Johnson Nutrition, and Nestle Nutrition. S.R. and A.M. declare no conflicts of interest. |
Vol 165 - N° 2
P. 389-394 - août 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
